INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 118 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $104,000 | +4.0% | 46,103 | +57.0% | 0.00% | – |
| Q3 2021 | $100,000 | +222.6% | 29,361 | +186.9% | 0.00% | – |
| Q2 2021 | $31,000 | +210.0% | 10,234 | -2.2% | 0.00% | – |
| Q4 2019 | $10,000 | -86.8% | 10,463 | -75.2% | 0.00% | – |
| Q2 2019 | $76,000 | +153.3% | 42,114 | +117.6% | 0.00% | – |
| Q3 2016 | $30,000 | -81.0% | 19,355 | +3.6% | 0.00% | – |
| Q3 2015 | $158,000 | +22.5% | 18,674 | +59.0% | 0.00% | – |
| Q2 2015 | $129,000 | -58.5% | 11,742 | -47.3% | 0.00% | -100.0% |
| Q1 2015 | $311,000 | -16.6% | 22,279 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $373,000 | +56.1% | 22,109 | +24.0% | 0.00% | 0.0% |
| Q3 2014 | $239,000 | -15.8% | 17,830 | -19.9% | 0.00% | 0.0% |
| Q2 2014 | $284,000 | +72.1% | 22,267 | +60.4% | 0.00% | – |
| Q1 2014 | $165,000 | – | 13,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,100,000 | $14,762,000 | 6.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,882,805 | $52,107,000 | 1.90% |
| Cheyne Capital Management (UK) LLP | 326,821 | $4,388,000 | 1.56% |
| BB BIOTECH AG | 2,320,737 | $31,144,000 | 1.27% |
| Broadfin Capital, LLC | 854,384 | $11,466,000 | 1.20% |
| HealthCor Management, L.P. | 1,162,200 | $15,597,000 | 0.80% |
| Orbimed Advisors | 4,736,900 | $63,569,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 148,000 | $1,986,000 | 0.58% |
| SOUND ENERGY PARTNERS, INC. | 51,000 | $684,000 | 0.53% |
| Rock Springs Capital Management LP | 210,000 | $2,818,000 | 0.44% |